欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DE/H/2368/001
药品名称
Zolmitriptan STADA 2,5 mg Tabletten
活性成分
zolmitriptan 2.5 mg
剂型
Tablet
上市许可持有人
Stadapharm GmbH Stadastrasse 2-18 61118 Bad Vilbel Germany
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
Denmark (DK)
Zolmitriptan Stada
Portugal (PT)
Sweden (SE)
Zolmitriptan STADA
Finland (FI)
许可日期
2010/01/29
最近更新日期
2023/09/12
药物ATC编码
N02CC03 zolmitriptan
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Product Information
|
final-common-smpc-2368-012
Date of last change:2020/07/06
Final Product Information
|
final-common-pil-2368-012
Date of last change:2020/07/06
Final SPC
|
DE2368_Zolmitriptan_SmPC_cl_20150108_renewal
Date of last change:2015/01/08
Final SPC
|
DE2369_Zolmitriptan_SmPC_cl_20150108_renewal
Date of last change:2015/01/08
Final SPC
|
DE2479-2480_Zolmitriptan_SmPC_cl_20150108_renewal
Date of last change:2015/01/08
Final PL
|
DE2368_Zolmitriptan_PIL_cl__20150108_renewal
Date of last change:2015/01/08
Final PL
|
DE2369_Zolmitriptan_PIL_cl_20150108_renewal
Date of last change:2015/01/08
Final PL
|
DE2479-2480_Zolmitriptan_PIL_cl_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2368_001_Zolmitriptan_lab_inner_present_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2368_001_Zolmitriptan_lab_outer_clean_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2368_002_Zolmitriptan_lab_inner_present_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2368_002_Zolmitriptan_lab_outer_clean_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2369_001_Zolmitriptan_lab_inner_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2369_001_Zolmitriptan_lab_outer_clean_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2369_002_Zolmitriptan_lab_inner_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2369_002_Zolmitriptan_LAB-outer_tc_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2479_001_Zolmitriptan_LAB-inner_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2479_001_Zolmitriptan_LAB-outer_clean_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2479_002_Zolmitriptan_LAB-inner_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2479_002_Zolmitriptan_LAB-outer_clean_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2480_001_Zolmitriptan_LAB-inner_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2480_001_Zolmitriptan_LAB-outer_clean_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2480_002_Zolmitriptan_LAB_outer_clean_20150108_renewal
Date of last change:2015/01/08
Final Labelling
|
DE2480_002_Zolmitriptan_LAB-inner_20150108_renewal
Date of last change:2015/01/08
PAR
|
PAREN-DE2368-69-DC-ZolmitriptanSTADA-20100608-final
Date of last change:2013/06/21
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase